gyki 52466 has been researched along with 1-(3-chlorophenyl)piperazine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barkóczy, J; Bilkei-Gorzó, A; Gacsályi, I; Hársing, LG; Hegedus, E; Kapus, GL; Kompagne, H; Lévay, G; Leveleki, C; Vegh, M | 1 |
1 other study(ies) available for gyki 52466 and 1-(3-chlorophenyl)piperazine
Article | Year |
---|---|
Antagonism of AMPA receptors produces anxiolytic-like behavior in rodents: effects of GYKI 52466 and its novel analogues.
Topics: Animals; Anti-Anxiety Agents; Benzodiazepines; Conflict, Psychological; Data Interpretation, Statistical; Diazepam; Electrophysiology; Excitatory Amino Acid Antagonists; Hippocampus; Male; Membrane Potentials; Mice; Motor Activity; Neurons; Patch-Clamp Techniques; Piperazines; Quinoxalines; Radioligand Assay; Rats; Rats, Wistar; Receptors, AMPA; Telencephalon | 2008 |